ARCHIVES

DRCCA To Get Name Change, Three Major Program Areas

This article is from The Cancer Letter archive.

Vol. 08 No. 33 | August 27, 1982

Download PDF Visit The Full Archive

Related Articles

Aging Committee Hears Prospects For Immunotherapy

July 27, 1979

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007

IOM Says “Immediate Steps” Needed To Avert “Crisis” In Cancer Centers Program Funding

April 28, 1989

Basic Biology Progress, Improved Survival Since 1971 Described By DeVita At Senate Hearing

February 27, 1981

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

October 22, 2004

INSPIRE Enrollment Stopped; Thromboembolism Risk Cited

February 25, 2011